Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SWKS vs MRNA✓SelectedUSD · MRNASWKS vs MRNA performance historyLatest closeAs of-6.04%11/20
Stock and ETF performance explorer

SWKS vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+31.6%
MRNA return
+786.4%
Excess return
-754.7%
Maximum drawdown
-72.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-6.0%-2.2%-3.9%-5.9%
7D-17.8%-12.7%-5.1%-17.1%
30D-10.1%-20.7%+10.6%-9.0%
3M+8.8%+46.3%-37.5%+5.3%
6M+0.3%+305.2%-305.0%-16.2%
YTD+19.0%+561.2%-542.3%-7.4%
1Y+24.7%+772.1%-747.4%-6.3%
3Y-14.6%+147.0%-161.6%-28.9%
5Y-47.0%-26.1%-21.0%-53.4%
All+31.6%+786.4%-754.7%+10.5%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling